BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21795023)

  • 1. Do patients with osteogenesis imperfecta need individualized nutritional support?
    Chagas CE; Roque JP; Santarosa Emo Peters B; Lazaretti-Castro M; Martini LA
    Nutrition; 2012 Feb; 28(2):138-42. PubMed ID: 21795023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls.
    Misra M; Aggarwal A; Miller KK; Almazan C; Worley M; Soyka LA; Herzog DB; Klibanski A
    Pediatrics; 2004 Dec; 114(6):1574-83. PubMed ID: 15574617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary antiphospholipid syndrome in premenopausal women: low vitamin D, high fat mass and maintained bone mineral mass.
    Paupitz JA; Freire de Carvalho J; Caparbo VF; Klack K; Pereira RM
    Lupus; 2010 Oct; 19(11):1302-6. PubMed ID: 20534647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthropometry, nutritional status, and dietary intake in pediatric patients with osteogenesis imperfecta.
    Zambrano MB; Brizola ES; Refosco L; Giugliani R; Félix TM
    J Am Coll Nutr; 2014; 33(1):18-25. PubMed ID: 24533604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and correlates of vitamin D status in children and adolescents with osteogenesis imperfecta.
    Edouard T; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3193-8. PubMed ID: 21832107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.
    Kocijan R; Muschitz C; Fahrleitner-Pammer A; Amrein K; Pietschmann P; Haschka J; Dinu S; Kapiotis S; Resch H
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E311-9. PubMed ID: 24203063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the Determinants of Vitamin D Status in Pediatric Patients With Osteogenesis Imperfecta.
    Zambrano MB; Brizola E; Pinheiro B; Vanz AP; Mello ED; Félix TM
    J Am Coll Nutr; 2016; 35(4):339-45. PubMed ID: 26709914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone density, parathyroid hormone, calcium and vitamin D nutritional status of institutionalized elderly subjects.
    Deplas A; Debiais F; Alcalay M; Bontoux D; Thomas P
    J Nutr Health Aging; 2004; 8(5):400-4. PubMed ID: 15359360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density.
    Ilich JZ; Brownbill RA; Tamborini L
    Eur J Clin Nutr; 2003 Apr; 57(4):554-65. PubMed ID: 12700617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study.
    Edouard T; Glorieux FH; Rauch F
    J Bone Miner Res; 2011 Sep; 26(9):2245-51. PubMed ID: 21544864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for vitamin D deficiency in children with osteogenesis imperfecta.
    Wilsford LD; Sullivan E; Mazur LJ
    J Pediatr Orthop; 2013; 33(5):575-9. PubMed ID: 23752159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate treatment in children with osteogenesis imperfecta.
    Akcay T; Turan S; Guran T; Bereket A
    Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P; Schott AM; Prockop D; Chevrel G
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium metabolism, vitamin D and bone mineral density after bariatric surgery.
    Costa TL; Paganotto M; Radominski RB; Kulak CM; Borba VC
    Osteoporos Int; 2015 Feb; 26(2):757-64. PubMed ID: 25388022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.
    Rauch F; Munns CF; Land C; Cheung M; Glorieux FH
    J Bone Miner Res; 2009 Jul; 24(7):1282-9. PubMed ID: 19257821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between bone mineral density and hearing loss in osteogenesis imperfecta.
    Swinnen FK; De Leenheer EM; Goemaere S; Cremers CW; Coucke PJ; Dhooge IJ
    Laryngoscope; 2012 Feb; 122(2):401-8. PubMed ID: 22252604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate treatment in osteogenesis imperfecta.
    Madenci E; Yilmaz K; Yilmaz M; Coskun Y
    J Clin Rheumatol; 2006 Apr; 12(2):53-6. PubMed ID: 16601536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.